BK

Brijesh Kumar

Director Director DIN 07904845
DIN 07904845 First appointment Sep 2017 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2017
Shareholding value •••• Premium profile

About Brijesh Kumar

Data last updated:

Brijesh Kumar was a Director at Byprio Pharmaceuticals Private Limited (2020–2024) and Director at Joymed Pharmaceuticals Private Limited (2017–2021). The companies operate in Chemicals.

DIN 07904845
Primary Designation Director
Industry Chemicals
First Appointment 06 Sep 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Nov 20202020₹24.8 Lakh (FY 2025)Active
Director06 Sep 20172017₹13.3 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Byprio Pharmaceuticals Private Limited
Joymed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Brijesh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Brijesh Kumar

Brijesh Kumar was first appointed on 06 Sep 2017 as Director at Joymed Pharmaceuticals Private Limited. The most recent appointment on record is 03 Nov 2020 at Byprio Pharmaceuticals Private Limited.

Brijesh Kumar held 2 earlier board appointments: Byprio Pharmaceuticals Private Limited (Director, 03 Nov 2020 to 14 Mar 2024); Joymed Pharmaceuticals Private Limited (Director, 06 Sep 2017 to 17 Sep 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available